|
1
|
Verdin H and De Baere E: FOXL2 impairment
in human disease. Horm Res Paediatr. 77:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosario R, Cohen PA and Shelling AN: The
role of FOXL2 in the pathogenesis of adult ovarian granulosa cell
tumours. Gynecol Oncol. 133:382–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Georges A, Auguste A, Bessière L, Vanet A,
Todeschini AL and Veitia RA: FOXL2: A central transcription factor
of the ovary. J Mol Endocrinol. 52:R17–R33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cocquet J, Pailhoux E, Jaubert F, Servel
N, Xia X, Pannetier M, De Baere E, Messiaen L, Cotinot C, Fellous M
and Veitia RA: Evolution and expression of FOXL2. J Med Genet.
39:916–921. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Uhlenhaut NH, Jakob S, Anlag K,
Eisenberger T, Sekido R, Kress J, Treier AC, Klugmann C, Klasen C,
Holter NI, et al: Somatic sex reprogramming of adult ovaries to
testes by FOXL2 ablation. Cell. 139:1130–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garcia-Ortiz JE, Pelosi E, Omari S,
Nedorezov T, Piao Y, Karmazin J, Uda M, Cao A, Cole SW, Forabosco
A, et al: Foxl2 functions in sex determination and histogenesis
throughout mouse ovary development. BMC Dev Biol. 9:362009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qian X, Shu A, Qin W, Xing Q, Gao J, Yang
J, Feng G and He L: A novel insertion mutation in the FOXL2 gene is
detected in a big Chinese family with
blepharophimosis-ptosis-epicanthus inversus. Mutat Res. 554:19–22.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li WX, Wang XK, Sun Y, Wang YL, Lin LX and
Tang SJ: A novel mutation in the FOXL2 gene in a Chinese family
with blepharophimosis, ptosis, and epicanthus inversus syndrome.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 22:372–375. 2005.PubMed/NCBI
|
|
9
|
Yu HC, Geiger EA, Medne L, Zackai EH and
Shaikh TH: An individual with blepharophimosis-ptosis-epicanthus
inversus syndrome (BPES) and additional features expands the
phenotype associated with mutations in KAT6B. Am J Med Genet A.
164A:950–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duffin K, Bayne RA, Childs AJ, Collins C
and Anderson RA: The forkhead transcription factor FOXL2 is
expressed in somatic cells of the human ovary prior to follicle
formation. Mol Hum Reprod. 15:771–777. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Caburet S, Georges A, LHôte D, Todeschini
AL, Benayoun BA and Veitia RA: The transcription factor FOXL2: At
the crossroads of ovarian physiology and pathology. Mol Cell
Endocrinol. 356:55–64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Auguste A, Chassot AA, Grégoire EP,
Renault L, Pannetier M, Treier M, Pailhoux E and Chaboissier MC:
Loss of R-spondin1 and Foxl2 amplifies female-to-male sex reversal
in XX mice. Sex Dev. 5:304–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai A, Sun H, Fang T, Zhang Q, Wu S, Jiang
Y, Ding L, Yan G and Hu Y: MicroRNA-133b stimulates ovarian
estradiol synthesis by targeting Foxl2. FEBS Lett. 587:2474–2482.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo Y, Wu X, Ling Z, Yuan L, Cheng Y, Chen
J and Xiang C: microRNA133a targets Foxl2 and promotes
differentiation of C2C12 into myogenic progenitor cells. DNA Cell
Biol. 34:29–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eiring AM, Page BD, Kraft IL, Mason CC,
Vellore NA, Resetca D, Zabriskie MS, Zhang TY, Khorashad JS, Engar
AJ, et al: Combined STAT3 and BCR-ABL1 inhibition induces synthetic
lethality in therapy-resistant chronic myeloid leukemia. Leukemia.
29:586–597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takeda K, Kaisho T, Yoshida N, Takeda J,
Kishimoto T and Akira S: Correction: Stat3 activation is
responsible for IL-6-dependent T cell proliferation through
preventing apoptosis: Generation and characterization of T
cell-specific Stat3-deficient mice. J Immunol. 194:35262015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee HJ, Zhuang G, Cao Y, Du P, Kim HJ and
Settleman J: Drug resistance via feedback activation of Stat3 in
oncogene-addicted cancer cells. Cancer Cell. 26:207–221. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Furqan M, Akinleye A, Mukhi N, Mittal V,
Chen Y and Liu D: STAT inhibitors for cancer therapy. J Hematol
Oncol. 6:902013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang T, Li F and Tang S: MiR-30a
upregulates BCL2A1, IER3 and cyclin D2 expression by targeting
FOXL2. Oncol Lett. 9:967–971. 2015.PubMed/NCBI
|
|
20
|
Pisarska MD, Barlow G and Kuo FT:
Minireview: Roles of the forkhead transcription factor FOXL2 in
granulosa cell biology and pathology. Endocrinology. 152:1199–1208.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kashimada K, Pelosi E, Chen H,
Schlessinger D, Wilhelm D and Koopman P: FOXL2 and BMP2 act
cooperatively to regulate follistatin gene expression during
ovarian development. Endocrinology. 152:272–280. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rosario R, Araki H, Print CG and Shelling
AN: The transcriptional targets of mutant FOXL2 in granulosa cell
tumours. PLoS One. 7:e462702012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosario R, Blenkiron C and Shelling AN:
Comparative study of microRNA regulation on FOXL2 between
adult-type and juvenile-type granulosa cell tumours in vitro.
Gynecol Oncol. 129:209–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tran S, Lamba P, Wang Y and Bernard DJ:
SMADs and FOXL2 synergistically regulate murine FSHbeta
transcription via a conserved proximal promoter element. Mol
Endocrinol. 25:1170–1183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng JC, Klausen C and Leung PC:
Overexpression of wild-type but not C134W mutant FOXL2 enhances
GnRH-induced cell apoptosis by increasing GnRH receptor expression
in human granulosa cell tumors. PLoS One. 8:e550992013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Benayoun BA, Batista F, Auer J,
Dipietromaria A, LHôte D, De Baere E and Veitia RA: Positive and
negative feedback regulates the transcription factor FOXL2 in
response to cell stress: Evidence for a regulatory imbalance
induced by disease-causing mutations. Hum Mol Genet. 18:632–644.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Staniszewska AD, Pensa S, Caffarel MM,
Anderson LH, Poli V and Watson CJ: Stat3 is required to maintain
the full differentiation potential of mammary stem cells and the
proliferative potential of mammary luminal progenitors. PLoS One.
7:e526082012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iwamaru A, Szymanski S, Iwado E, Aoki H,
Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, et al: A
novel inhibitor of the STAT3 pathway induces apoptosis in malignant
glioma cells both in vitro and in vivo. Oncogene. 26:2435–2444.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daniel JM, Dutzmann J, Bielenberg W,
Widmer-Teske R, Gündüz D, Hamm CW and Sedding DG: Inhibition of
STAT3 signaling prevents vascular smooth muscle cell proliferation
and neointima formation. Basic Res Cardiol. 107:2612012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Redell MS, Ruiz MJ, Alonzo TA, Gerbing RB
and Tweardy DJ: Stat3 signaling in acute myeloid leukemia:
Ligand-dependent and -independent activation and induction of
apoptosis by a novel small-molecule Stat3 inhibitor. Blood.
117:5701–5709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gad SE and Sullivan DW: Dimethyl Sulfoxide
(DMSO)Encyclopedia Toxicol. Wexler P: 3rd. Academic Press/Elsevier;
London: pp. 166–168. 2014, View Article : Google Scholar
|
|
33
|
Galvao J, Davis B, Tilley M, Normando E,
Duchen MR and Cordeiro MF: Unexpected low-dose toxicity of the
universal solvent DMSO. FASEB J. 28:1317–1330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JH, Yoon S, Park M, Park HO, Ko JJ,
Lee K and Bae J: Differential apoptotic activities of wild-type
FOXL2 and the adult-type granulosa cell tumor-associated mutant
FOXL2 (C134W). Oncogene. 30:1653–1663. 2011. View Article : Google Scholar : PubMed/NCBI
|
